Tandem Diabetes Care Inc (TNDM)
As of Sep 19, 2026, Tandem Diabetes Care Inc (TNDM) scores 1.6/10 on AlphaStocks' five-model composite, #168 of 168 Health Care stocks.
Health Care / Health Care Equipment
S&P SmallCap 600$16.86
Scores poorly across most models. Proceed with caution.
Avoid
Score based on 4 of 5 models — moderate confidence
Data as of Sep 19, 2026
Is TANDEM DIABETES CARE INC a Good Investment in 2026?
TANDEM DIABETES CARE INC (TNDM) scores 1.6 out of 10 on AlphaStocks' composite model, earning a Avoid rating. The Piotroski model is the most favorable, rating TANDEM DIABETES CARE INC as Neutral. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield -14.9% · ROC -41%. TANDEM DIABETES CARE INC ranks #168 out of 168 stocks in the Health Care sector.
This summary is algorithmically generated and is not financial advice.
Key Metrics
Valuation
Currently unprofitable — fair value estimate not available.
Fair value estimate not available for this stock.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Neutral
4/9
Buffett
Caution
Business quality & competitive moat
Graham
Neutral
Price vs intrinsic value
Lynch
Limited Data
Growth rate vs price (PEG)
Greenblatt
Caution
Earnings yield -14.9% · ROC -41%
Frequently Asked Questions
Is TANDEM DIABETES CARE INC (TNDM) a good investment?
What is TANDEM DIABETES CARE INC's Piotroski F-Score?
Is TNDM overvalued or undervalued?
How does TNDM compare to other Health Care stocks?
What do investment models say about TNDM?
Similar Stocks
Compare TNDM with
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer